| 1st Feb 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Feb 2023 7:05 am |
RNS |
Benlysta granted Orphan Drug Designation by US FDA |
| 1st Feb 2023 7:00 am |
RNS |
Final Results |
| 18th Jan 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Jan 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jan 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 12th Jan 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Jan 2023 3:00 pm |
RNS |
Total Voting Rights |
| 22nd Dec 2022 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 21st Dec 2022 3:35 pm |
RNS |
Director/PDMR Shareholding |
| 21st Dec 2022 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Dec 2022 3:30 pm |
RNS |
Board and Committee Changes |
| 13th Dec 2022 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 7th Dec 2022 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation |
| 5th Dec 2022 4:00 pm |
RNS |
Transfer of Treasury Shares |
| 2nd Dec 2022 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Dec 2022 7:00 am |
RNS |
EMA file accepted for momelotinib |
| 2nd Dec 2022 7:00 am |
RNS |
Jemperli positive trial in endometrial cancer |
| 1st Dec 2022 3:00 pm |
RNS |
Total Voting Rights |
| 25th Nov 2022 4:47 pm |
RNS |
Publication of Final Terms of EMTN Notes |
| 24th Nov 2022 3:00 pm |
RNS |
GSK publishes provisional 2023 dividend dates |
| 22nd Nov 2022 4:00 pm |
RNS |
Publication of Supplementary EMTN Prospectus |
| 22nd Nov 2022 7:00 am |
RNS |
Blenrep US Update |
| 21st Nov 2022 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 18th Nov 2022 4:00 pm |
RNS |
Publication of EMTN Supplementary Prospectus |
| 15th Nov 2022 4:00 pm |
RNS |
Block listing Interim Review |
| 15th Nov 2022 3:53 pm |
RNS |
Final results of outstanding Notes Tender Offer |
| 15th Nov 2022 7:00 am |
RNS |
Interim results of outstanding Notes Tender Offer |
| 11th Nov 2022 7:00 am |
RNS |
GSK Update: Zejula 2L in US |
| 10th Nov 2022 6:10 pm |
RNS |
Sanofi-GSK COVID booster vaccine approved by EU |
| 10th Nov 2022 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Nov 2022 9:00 am |
RNS |
Block Listing Application |
| 8th Nov 2022 9:26 am |
RNS |
Launch of Tender Offer for outstanding Notes |
| 7th Nov 2022 7:00 am |
RNS |
DREAMM-3 phase III trial for Blenrep |
| 3rd Nov 2022 1:00 pm |
RNS |
Publication of Suppl.Prospcts |
| 3rd Nov 2022 7:00 am |
RNS |
IDMC recommends gepotidacin early efficacy stop |
| 2nd Nov 2022 7:01 am |
RNS |
3rd Quarter Results |
| 2nd Nov 2022 7:00 am |
RNS |
GSK RSV vaccine: US FDA Priority Review |
| 1st Nov 2022 3:00 pm |
RNS |
Total Voting Rights |
